Biomarker services
Compound partnering resources spanning the R&D continuum to provide early compound assessment and development within a proven, innovative compound partnering program.
Development Services (Pharma, Biotech, Medical Device, Government and Academia):
* Phase I clinic
* Phase II-IV trial management and monitoring
* Bioanalytical labs
* Biomarker services
* Biostatistics
* cGMP labs
* Data management
* Global central labs
* Interactive voice response systems
* Medical affairs
* Medical devices
* Medical information
* Medical writing
* Patient recruitment and site enrollment
* Pharmacovigilance and safety support
* Program management
* Regulatory management and dossier submissions
* Post-approval services
o Epidemiology, risk management and outcomes research
o Late stage trials
o Medical information
o Product safety
o Registries and observational studies
* Therapeutic and specialty groups
o Central nervous system
o Circulatory/cardiopulmonary
o Endocrine/metabolic
o Gov/NGO PharmaServices
o Hematology/oncology
o Immunology
o Infectious diseases
o Ophthalmology
* CSS Informatics (division of PPD) — consulting services and proprietary e-technologies for clinical and safety data management, validation and training services for Oracle Clinical.
Key to PPD's continued success is its ability to forge innovative alliances and strategic outsourcing partnerships that capture cost-efficiences and speed drug development, as it did with Merck & Co., Inc., in 2008. In this strategic collaboration, PPD acquired Merck's vaccines and biologics infrastructure, broadened its therapeutics expertise and significantly expanded its existing relationship with the pharmaceutical company.
With operations spanning six continents to meet the regional and multinational needs of clients, PPD continues to earn recognition as a leader in the industry. PPD was honored when Forbes again selected PPD for its Platinum 400 list of the best big companies in America and as the best-managed company in the health care equipment and services category.
With offices in 38 countries and approximately 10,500 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help its clients and partners maximize returns on their R&D investments and accelerate the delivery of safe and effective therapeutics to patients. 
